Syndax Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
14 Jun 24 | Buy€23,407 | Keith Goldan | Individual | 1,250 | €18.73 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 339,316 | 0.377% |
Hedge Funds | 5,842,925 | 6.5% |
Institutions | 83,716,244 | 93.1% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.6%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
8,239,050 | €126.5m | 4.2% | no data | |||
5,842,925 | €89.7m | 2.11% | 7.13% | |||
4,985,976 | €76.6m | -32.1% | 0.01% | |||
4,886,974 | €75.1m | 1.87% | no data | |||
4,105,313 | €63.0m | 13.6% | 5.33% | |||
3,888,437 | €59.7m | 0% | 0.84% | |||
3,770,826 | €57.9m | 4.1% | no data | |||
2,788,931 | €42.8m | -0.57% | 0.11% | |||
2,455,000 | €37.7m | -26.4% | 2.17% | |||
1,977,082 | €30.4m | 3.48% | no data | |||
1,925,300 | €29.6m | 0% | 0.42% | |||
1,896,032 | €29.1m | 22.7% | 0.25% | |||
1,740,715 | €26.7m | 12.5% | 0.01% | |||
1,731,191 | €26.6m | 22.6% | 8.65% | |||
1,262,898 | €19.4m | 10.7% | 0.01% | |||
1,187,165 | €18.2m | 85.4% | 3.07% | |||
1,119,963 | €17.2m | 5.11% | 0.01% | |||
1,090,984 | €16.8m | 32% | 1.26% | |||
1,034,846 | €15.9m | 25.9% | 2.87% | |||
1,025,000 | €15.7m | 0% | 6.49% | |||
1,000,000 | €15.4m | 11.7% | 2.31% | |||
998,619 | €15.3m | 2.94% | 0.05% | |||
989,904 | €15.2m | -45.9% | 0.02% | |||
937,250 | €14.4m | 42.8% | 0.04% | |||
886,494 | €13.6m | -4.78% | 0.03% |